{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:20:40Z","timestamp":1785194440657,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.biopha.2015.12.027","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T12:19:32Z","timestamp":1460117972000},"page":"381-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression"],"prefix":"10.1016","volume":"80","author":[{"given":"Juan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.027_bib0010","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA: Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3802\/jgo.2015.26.2.156","article-title":"Major clinical research advances in gynecologic cancer in 2014","volume":"26","author":"Suh","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.027_bib0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbagen.2007.09.010","article-title":"Mucin-type O-glycosylation and its potential use in drug and vaccine development","volume":"1780","author":"Tarp","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.027_bib0025","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwg007","article-title":"All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases","volume":"13","author":"Ten Hagen","year":"2003","journal-title":"Glycobiology"},{"issue":"7","key":"10.1016\/j.biopha.2015.12.027_bib0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjc.6600536","article-title":"N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers","volume":"87","author":"Dosaka-Akita","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2015.12.027_bib0035","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/thy.2012.0613","article-title":"Expression of polypeptide N-acetylgalactosaminyl transferase-3 and its association with clinicopathological factors in thyroid carcinomas","volume":"23","author":"Mochizuki","year":"2013","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/bjc.2013.331","article-title":"Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas","volume":"109","author":"Kitada","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2015.12.027_bib0045","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/bjc.2011.166","article-title":"Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival","volume":"104","author":"Li","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2015.12.027_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1593\/neo.101440","article-title":"Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin","volume":"13","author":"Park","year":"2011","journal-title":"Neoplasia (New York, N. Y.)"},{"key":"10.1016\/j.biopha.2015.12.027_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2407-10-123","article-title":"N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry","volume":"10","author":"Wu","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3892\/or.2013.2493","article-title":"The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13","volume":"30","author":"Wang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.027_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10120-014-0340-8","article-title":"DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer","volume":"18","author":"Li","year":"2015","journal-title":"Gastric Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2015.12.027_bib0075","first-page":"1027","article-title":"Down-regulation of microRNA-205 promotes gastric cancer cell proliferation","volume":"18","author":"Yin","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.027_bib0080","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1159\/000354527","article-title":"miR-200b suppresses cell growth, migration and invasion by targeting Notch1 in nasopharyngeal carcinoma","volume":"32","author":"Yang","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2015.12.027_bib0085","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/jcmm.12317","article-title":"Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers","volume":"18","author":"Liu","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.027_bib0090","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.18632\/oncotarget.3065","article-title":"MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2015.12.027_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-015-3356-8","article-title":"Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma","author":"Duan","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbrc.2013.10.052","article-title":"miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1","volume":"441","author":"Guo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.027_bib0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1309\/AJCPLYTZGB54ISZC","article-title":"miR-335 represents an independent prognostic marker in epithelial ovarian cancer","volume":"141","author":"Cao","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.027_bib0110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/or.2013.2482","article-title":"miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w","volume":"30","author":"Cao","year":"2013","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2015.12.027_bib0115","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1007\/s13277-014-2546-0","article-title":"MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2","volume":"35","author":"Feng","year":"2014","journal-title":"Tumour Biol."},{"issue":"2 Pt. B","key":"10.1016\/j.biopha.2015.12.027_bib0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.canlet.2014.11.011","article-title":"miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma","volume":"356","author":"Kim","year":"2015","journal-title":"Cancer Lett."},{"issue":"Pt. 13","key":"10.1016\/j.biopha.2015.12.027_bib0125","first-page":"2867","article-title":"microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn","volume":"126","author":"Ninio-Many","year":"2013","journal-title":"J. Cell Sci."},{"issue":"46","key":"10.1016\/j.biopha.2015.12.027_bib0130","doi-asserted-by":"crossref","first-page":"32276","DOI":"10.1074\/jbc.M114.584136","article-title":"MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor alpha: implications for cancer therapeutics","volume":"289","author":"Tiwari","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2015.12.027_bib0135","doi-asserted-by":"crossref","first-page":"e40169","DOI":"10.1371\/journal.pone.0040169","article-title":"Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF","volume":"7","author":"Bi","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2015.12.027_bib0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejca.2014.12.007","article-title":"MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas","volume":"51","author":"Gattolliat","year":"2015","journal-title":"Eur. J. Cancer (Oxford, England: 1990)"},{"issue":"5","key":"10.1016\/j.biopha.2015.12.027_bib0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4161\/rna.6.5.10079","article-title":"MicroRNA-125a represses cell growth by targeting HuR in breast cancer","volume":"6","author":"Guo","year":"2009","journal-title":"RNA Biol."},{"issue":"9","key":"10.1016\/j.biopha.2015.12.027_bib0150","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","article-title":"MicroRNA expression profiles in serous ovarian carcinoma","volume":"14","author":"Nam","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.027_bib0155","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000354469","article-title":"SIRT4 prevents hypoxia-induced apoptosis in H9c2 cardiomyoblast cells","volume":"32","author":"Liu","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.biopha.2015.12.027_bib0160","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1593\/neo.09942","article-title":"The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells","volume":"11","author":"Cowden Dahl","year":"2009","journal-title":"Neoplasia (New York, N. Y.)"},{"issue":"12","key":"10.1016\/j.biopha.2015.12.027_bib0165","doi-asserted-by":"crossref","first-page":"12593","DOI":"10.1007\/s13277-014-2581-x","article-title":"MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14)","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"7","key":"10.1016\/j.biopha.2015.12.027_bib0170","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00405-013-2818-0","article-title":"MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration","volume":"271","author":"Zhu","year":"2014","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"issue":"4","key":"10.1016\/j.biopha.2015.12.027_bib0175","doi-asserted-by":"crossref","first-page":"e0122851","DOI":"10.1371\/journal.pone.0122851","article-title":"MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"33","key":"10.1016\/j.biopha.2015.12.027_bib0180","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1200\/JCO.2011.37.2623","article-title":"Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer","volume":"29","author":"Soria","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.027_bib0185","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3892\/ol.2014.2507","article-title":"Genotyping the gene by joint analysis of two linked single nucleotide polymorphisms using liver tissues for clinical and geographical comparisons","volume":"8","author":"Liang","year":"2014","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2015.12.027_bib0190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3892\/mco.2014.294","article-title":"Genotype, alpha-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma","volume":"2","author":"Lin","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.biopha.2015.12.027_bib0195","article-title":"Vmediates tumor invasion and migration in breast cancer cell MCF-7","author":"Huanna","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"9","key":"10.1016\/j.biopha.2015.12.027_bib0200","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nm1627","article-title":"Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL","volume":"13","author":"Wagner","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2015.12.027_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0070-2153(06)78001-2","article-title":"Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways","volume":"78","author":"Carraway","year":"2007","journal-title":"Curr. Top. Dev. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215302559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215302559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:03:15Z","timestamp":1760094195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215302559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"alternative-id":["S0753332215302559"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.12.027","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}